Spruce Biosciences, Inc.
NASDAQ:SPRBBiotechnology
+$2.47 today
- Market cap
- $116.37M
- Beta
- 3.20
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$27.11
Volume 0.05M
Average 0.06M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Spruce Biosciences, Inc.
NASDAQ:SPRB
Intrinsic Alpha fair value
Locked
Current Price
$40.49
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | N/A | N/A3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Cue Biopharma, Inc. NASDAQ:CUE | $117.10M | $16.12 | Not rated | -6.7 | -13.07% |
Outlook Therapeutics, Inc. NASDAQ:OTLK | $100.54M | $0.41 | Not rated | -2.1 | -78.67% |
NRx Pharmaceuticals, Inc. NASDAQ:NRXP | $94.82M | $2.19 | Not rated | -5.3 | +25.62% |
Equillium, Inc. NASDAQ:EQ | $81.80M | $1.29 | Not rated | -15.3 | +10.89% |
vTv Therapeutics Inc. NASDAQ:VTVT | $77.85M | $19.69 | Not rated | 128.7 | -48.11% |
Werewolf Therapeutics, Inc. NASDAQ:HOWL | $47.64M | $0.98 | Not rated | -1.4 | +20.51% |
Coeptis Therapeutics, Inc. NASDAQ:COEP | $38.62M | $10.99 | Not rated | -8.3 | -10.24% |
OS Therapies Incorporated AMEX:OSTX | $34.87M | $0.75 | Not rated | -2.0 | -29.01% |
Continue the stock analysis
Jump to another research area for this company.